A Book Review on :
AI doctor : the rise of artificial intelligence in healthcare : a guide for users, buyers, builders, and investors.
Razmi, Ronald. M. (Hoboken, NJ, United States: Wiley), 2023, 368 pages, ISBN: 978-1394240166
Ronald M. Razmi’s AI Doctor: The Rise of Artificial Intelligence in Healthcare is a timely and comprehensive exploration of how artificial intelligence (AI) is transforming medicine. Published in 2023, the book arrives at a pivotal moment shaped by the aftermath of COVID-19, rapid digital health advances, and growing ethical concerns around AI. The pandemic had exposed deep systemic vulnerabilities in healthcare systems worldwide, from overwhelmed hospitals to the exhaustion and attrition of frontline healthcare workers. Simultaneously, healthcare costs surged, driven by aging populations, the increasing prevalence of chronic diseases, and inflationary pressures on pharmaceuticals and labor. These challenges underscored the need for scalable, efficient healthcare delivery.
Digital health tools such as telemedicine, wearable monitoring systems, and algorithmic decision support gained widespread traction during the pandemic and have continued expanding in its aftermath. However, institutional skepticism has remained persistent. Concerns about data privacy, algorithmic opacity, liability, and regulatory uncertainty have slowed AI adoption. For example, clinicians have raised concerns over the interpretability of AI-generated recommendations and the implications for professional accountability should adverse outcomes occur. This tension reflects the gap between AI’s theoretical promise and the practical barriers of fragmented data, rigid clinical norms, and real-world complexity. Despite technological progress, fully integrating AI into healthcare workflows remains a challenge shaped as much by social and institutional dynamics as by technical feasibility.
In this context, Razmi offers a clear and multidimensional guide to understanding where AI currently stands within the healthcare ecosystem and how it may evolve. Drawing from a career that spans clinical cardiology, healthcare consulting, and digital health entrepreneurship, Razmi brings a uniquely interdisciplinary perspective. “AI Doctor” emerges as an informative and essential contribution for anyone seeking to understand the interface between emerging technology and healthcare reform.
Overview of the Book
The book is organized into three major sections. The first, “Roadmap,” traces the evolution of AI technology and its growing relevance to healthcare. Beginning with Alan Turing’s foundational ideas in the 1950s, the section covers developments in machine learning, deep learning, and large-scale multimodal models. Razmi introduces essential AI and machine learning concepts and provides a clear classification of algorithm types, offering insight into how these technologies are being used to identify patterns, automate diagnostics, and assist in clinical reasoning.
This section transitions into the practical challenges of building robust medical algorithms, emphasizing the importance of responsible AI. Razmi stresses that key principles such as fairness, transparency, safety, and accountability must be embedded into AI systems from the outset.
Unlike traditional medical devices or pharmaceuticals, AI models are dynamic; they evolve over time and may behave inconsistently in new contexts. This creates risks when applied in clinical settings. Razmi advocates for forward-looking governance frameworks, peer review mechanisms, and continuous risk assessment to safeguard their use. He highlights the concept of responsible AI not as a checklist but as an ongoing ethical commitment.
Questions surrounding bias, model transparency, and unintended consequences such as disproportionate impacts on vulnerable populations are addressed as core concerns. In this regard, Razmi incorporates insights from real-world initiatives like the Coalition for Health AI’s Blueprint for Trustworthy AI, which offers concrete recommendations for bias mitigation, fairness, usability, and long-term monitoring.
The section also delves into systemic barriers to implementation. These include regulatory fragmentation, a lack of reimbursement incentives, insufficient clinical evidence, and gaps in the workforce needed to operationalize AI effectively. Nevertheless, Razmi points to countervailing trends that drive progress, such as the expansion of health data, advances in computing infrastructure, rising investment, and the urgent need to ease pressure on overstretched health systems. Together, these factors shape the complex interplay between innovation and inertia in healthcare AI adoption.
The second section, “Applications of AI in Healthcare,” explores how AI is currently being used across diverse domains. Drawing from current research, regulatory case studies, and commercial ventures, Razmi examines AI applications in diagnostics, treatment optimization, administrative processes, and population health. High-impact fields such as radiology and ophthalmology receive particular attention, with discussions of FDA-cleared tools for image analysis and clinical decision support.
The section further addresses population-level applications, such as predictive models for hospital readmissions, sepsis detection, and pandemic forecasting. These examples provide insight into the potential and limitations of AI when applied to real-world data in complex environments. Razmi is careful to acknowledge ongoing challenges, including the siloed nature of datasets, the lack of external validation for many algorithms, and the tendency for AI systems to be implemented without sufficient clinical oversight. Importantly, the book underscores the role of clinicians in shaping meaningful AI integration. Razmi emphasizes that domain expertise must be involved throughout model development, validation, and deployment to ensure clinical relevance. This collaborative approach builds trust and bridges the gap between technical innovation and medical practice.
The final section, “The Business Case for AI in Healthcare,” turns to the economic and strategic factors influencing AI adoption. Razmi unpacks the conflicting priorities of healthcare stakeholders — providers, payers, policymakers, tech firms, and investors—and how these influence the uptake of AI solutions. He explains why technically sound innovations can still fail to scale if they do not align with institutional goals, financial incentives, or operational realities.
Drawing on his background in health technology entrepreneurship and venture capital, Razmi analyzes the structural and funding-related challenges startups face. These include navigating regulatory processes, securing reimbursement, building provider trust, and scaling solutions across fragmented health systems. The book critiques hype-driven funding models and emphasizes the importance of disciplined investment based on clinical impact, usability, and system integration.
Razmi offers a framework to assess which AI applications are most likely to succeed. He distinguishes near-term opportunities, such as administrative automation and workflow optimization, from longer-term, high-risk innovations like fully autonomous diagnostic tools. This pragmatic approach helps readers assess innovation through both a technical and commercial lens.
Transparency for Trustworthy Medical AI
Razmi’s discussion of data labeling and algorithmic transparency underscores a central theme in the development of reliable medical AI. Without rigorous oversight of how data are collected, annotated, and used in training, even the most sophisticated models risk producing unreliable or biased outcomes. In healthcare, where AI systems increasingly inform decisions about diagnosis and treatment, the consequences of poor data quality or opaque model behavior can be severe. As the book makes clear, transparency is not simply a desirable design feature, it is a foundational requirement for building trust among clinicians, regulators, and patients.
A particularly notable chapter is 2.6, “Data Labeling and Transparency,” which effectively illustrates both the operational challenges and ethical stakes involved in preparing data for medical AI. Razmi explains that most AI models in healthcare rely on supervised learning, which requires large volumes of manually labeled data, a process that is both costly and time-consuming. He provides concrete examples, such as DeepMind’s collaboration with Moorfields Eye Hospital, which involved the manual review of over 14,000 retinal scans, and the NIH’s release of over 32,000 annotated CT lesions. These cases underscore the scale of effort and clinical expertise required to ensure data quality. Razmi also highlights promising alternatives, such as self-supervised learning and human-in-the-loop annotation systems, which aim to reduce labor demands while maintaining reliability. Examples from this chapter effectively connect technical development to broader concerns about trust, transparency, and accountability in medical AI.
These examples underscore that transparency in data preparation is essential for both scientific reproducibility and real-world applicability. Razmi explains that mislabeled or inconsistently prepared datasets can introduce subtle but significant risks into AI systems, including diagnostic inaccuracies and biased recommendations. He stresses that developers must ensure both data quality and full transparency across the training pipeline, so that sources, labeling methods, and model assumptions can be audited and understood by external reviewers. This perspective echoes broader concerns raised by
Pasquale (2015), who warns that opaque algorithmic systems can reinforce asymmetries of power and obscure accountability, especially in domains like healthcare where decisions have high stakes. Situating Razmi’s discussion within this broader critique strengthens the argument that transparency must be treated not just as a best practice but as a fundamental requirement for ethical governance in medical AI.
Responsible AI as a Safeguard for Ethical Healthcare
Razmi’s discussion of responsible AI brings into sharp focus the broader societal and ethical responsibilities that come with the integration of machine learning into healthcare. While technical performance and efficiency often dominate conversations around AI, the book emphasizes that concepts such as fairness, safety, reliability, and accountability must be embedded into AI systems from the very beginning. In high-stakes fields like medicine, the failure to anticipate how a model behaves across different populations and clinical contexts can result in unintended harm, making the pursuit of responsible AI not optional but essential.
One of the book’s most compelling insights is its comparison between the regulatory paths of traditional medical interventions, such as drugs or devices, and those of machine learning systems. Unlike pharmaceuticals, which undergo rigorous and standardized clinical trials, AI algorithms are dynamic: they continue to evolve over time and may behave unpredictably depending on new inputs or shifting contexts. This “living” nature of AI poses unique challenges for validation, monitoring, and accountability, especially when these models are deployed in real-world care environments.
Razmi highlights this risk by pointing to the emergence of real-time, adaptive AI systems that essentially function as live experiments within clinical settings. Because these systems can’t be easily vetted using static, pre-deployment trials alone, ethical oversight must be ongoing. Here, frameworks like the Coalition for Health AI’s Blueprint for Trustworthy AI, published in late 2022, offer practical guidance. They propose principles such as testability, long-term monitoring, and health equity by design, which serve as essential guardrails for both developers and institutions aiming to deploy AI responsibly.
This perspective resonates deeply in today’s healthcare landscape, where historical disparities in access and outcomes continue to persist. Without deliberate attention to fairness, AI systems risk amplifying existing inequities, for instance, by performing poorly on underrepresented patient groups due to biased training data or by introducing unintended exclusions through data requirements. Responsible AI thus functions as a corrective mechanism, ensuring that innovation does not come at the expense of inclusivity, safety, or public trust. Razmi further emphasizes that engaging clinicians in the development and deployment process is critical. Understanding how a model will actually be used, what assumptions users make, what decisions they delegate, and what contextual information may be overlooked, helps surface potential misuses before they translate into real-world harm. Asking not just “what can this model do?” but “how will this model behave under uncertainty, and who might it fail?” reframes AI as an ethical system as much as a technical one.
Conclusion
“AI Doctor” offers not only a timely and well-researched account of how AI is reshaping healthcare, but also a clear and pragmatic framework for navigating the complex intersection of technology, clinical practice, and societal values. Through this approach, Razmi effectively engages a broad spectrum of readers ranging from clinicians and technologists to policymakers and investors by addressing their distinct concerns and priorities. For these diverse audiences, the book provides not only technical clarity but also strategic perspective and ethical insight, tailored to their respective roles in shaping the future of healthcare. Its lucid explanations, balanced tone, and grounding in real-world examples make it both accessible and substantial.
Most importantly, it challenges readers to look beyond technological feasibility, calling attention to the imperatives of transparency, accountability, and equity in the development of Trustworthy AI systems. Even as the field continues to evolve at a rapid pace, Razmi’s insights remain a steady and valuable compass for guiding the responsible and meaningful integration of intelligent technologies into modern healthcare.